Evidence map›Paper›PMID 33980931›Full record

Observational studyScientific reports2021

COVID-19's natural course among ambulatory monitored outpatients.

Barbora Weinbergerova, Jiri Mayer, Stepan Hrabovsky, Zuzana Novakova, Zdenek Pospisil, Lucie Martykanova, Katerina Hortova, Lucie Mandelova, Karel Hejduk, Renata Chloupková and 12 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 3 institutions in 1 country.

Barbora Weinbergerova *Department of Internal Medicine, Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic. Weinbergerova.Barbora@fnbrno.cz.
Jiri Mayer *Department of Internal Medicine, Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic.
Stepan HrabovskyDepartment of Internal Medicine, Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic.
Zuzana NovakovaDepartment of Internal Medicine, Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic.
Zdenek PospisilDepartment of Mathematics and Statistics, Faculty of Science, Masaryk University, Brno, Czech Republic.
Lucie MartykanovaInstitute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic.
Katerina HortovaInstitute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic.
Lucie MandelovaInstitute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic.
Karel HejdukInstitute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic.
Renata ChloupkováInstitute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic.
Michal PospisilDepartment of Nursing and Midwifery, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Martina DoubkovaDepartment of Respiratory Diseases, Masaryk University and University Hospital Brno, Brno, Czech Republic.
Vladimir MarekDepartment of Internal Medicine, Geriatrics and Practical Medicine, Masaryk University and University Hospital Brno, Brno, Czech Republic.
Renata NovotnaGeneral Practitioner's Office, Berkova 2390/107, 61200, Brno, Czech Republic.
Martin DolecekDepartment of Anesthesiology and Intensive Care Medicine, Masaryk University and University Hospital Brno, Brno, Czech Republic.
Hana Matejovska KubesovaDepartment of Internal Medicine, Geriatrics and Practical Medicine, Masaryk University and University Hospital Brno, Brno, Czech Republic.
Kristian BratDepartment of Respiratory Diseases, Masaryk University and University Hospital Brno, Brno, Czech Republic.
Radana ParizkovaDepartment of Infectious Diseases, Masaryk University and University Hospital Brno, Brno, Czech Republic.
Petr HusaDepartment of Infectious Diseases, Masaryk University and University Hospital Brno, Brno, Czech Republic.
Marek MechlDepartment of Radiology and Nuclear Medicine, Masaryk University and University Hospital Brno, Brno, Czech Republic.
Zdenek KralDepartment of Internal Medicine, Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic.
Martina LengerovaDepartment of Internal Medicine, Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic.
Masaryk University · CZUniversity Hospital Brno · CZInstitute of Health Information and Statistics · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Research objective was to detail COVID-19's natural trajectory in relation to the Czech population's viral load. Our prospective detailed daily questionnaire-based telemonitoring study evaluated COVID-19's impact among 105 outpatients. In accordance with government quarantine requirements, outpatients were divided into a cohort with two negative tests at the end of the disease (40 patients) and a cohort with a new algorithm (65 patients) following a 14-day quarantine. Median follow-up differed significantly between the 2 groups (23 days vs. 16 days). Only 6% of patients were asymptomatic during the entire telemonitoring period. Another 13% of patients were diagnosed asymptomatic, as suspected contacts, yet later developed symptoms, while the remaining 81% were diagnosed as symptomatic on average 6 days following symptom onset. Telemonitoring enabled precise symptom status chronicling. The most frequently reported complaints were fevers, respiratory issues, and anosmia. Six patients were eventually hospitalized for complications detected early after routine telemonitoring. During the extended follow-up (median 181 days), anosmia persisted in 26% of patients. 79% of patients in the new quarantine algorithm cohort reported no symptoms on day 11 compared to just 56% of patients in the two negative test cohort upon first testing negative (median-19 days). The highest viral load occurred within 0-2 days of initial symptom onset. Both the PCR viral load and two consecutive PCR negative sample realizations indicated high interindividual variability with a surprisingly fluctuating pattern among 43% of patients. No definitive COVID-19 symptoms or set of symptoms excepting anosmia (59%) and/or ageusia (47%) were identified. No preexisting medical conditions specifically foreshadowed disease trajectory in a given patient. Without a PCR negativity requirement for quarantine cessation, patients could exhibit fewer symptoms. Our study therefore highlights the urgent need for routine ambulatory patient telemedicine monitoring, early complication detection, intensive mass education connecting disease demeanor with subsequent swift diagnostics, and, notably, the need to reevaluate and modify quarantine regulations for better control of SARS-CoV-2 proliferation.

Indexed as

AdultAmbulatory Care FacilitiesCOVID-19Czech RepublicDisease ManagementFemaleHumansMaleMiddle AgedOutpatientsProspective StudiesQuarantineSARS-CoV-2TelemedicineViral Load

Identifiers

PMID33980931
PMCPMC8115337
OpenAlexW3130952497

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.